MedPath

福建海西新药创制股份有限公司

Ownership
-
Established
2012-03-27
Employees
-
Market Cap
-
Website
www.hxpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Bisoprolol Fumarate and Amlodipine Besilate Tablets

Product Name
比索洛尔氨氯地平片
Approval Number
国药准字H20249542
Approval Date
Dec 1, 2024
NMPA

Agomelatine Tablets

Product Name
阿戈美拉汀片
Approval Number
国药准字H20249011
Approval Date
Sep 26, 2024
NMPA

Cobamamide Capsules

Product Name
腺苷钴胺胶囊
Approval Number
国药准字H20244639
Approval Date
Aug 5, 2024
NMPA

Diclofenac Sodium Enteric-coated Tablets

Product Name
双氯芬酸钠肠溶片
Approval Number
国药准字H20244225
Approval Date
Jun 28, 2024
NMPA

Rebamipide Tablets

Product Name
瑞巴派特片
Approval Number
国药准字H20243604
Approval Date
Apr 24, 2024
NMPA

Amlodipine Besilate and Atorvastatin Calcium Tablets

Product Name
氨氯地平阿托伐他汀钙片
Approval Number
国药准字H20247071
Approval Date
Apr 18, 2024
NMPA

Nicergoline Tablets

Product Name
尼麦角林片
Approval Number
国药准字H20234574
Approval Date
Nov 28, 2023
NMPA

Hydroxychloroquine Sulfate Tablets

Product Name
硫酸羟氯喹片
Approval Number
国药准字H20234411
Approval Date
Oct 27, 2023
NMPA

Valsartan Tablets

Product Name
缬沙坦片
Approval Number
国药准字H20223428
Approval Date
Jun 28, 2022
NMPA

Valsartan Tablets

Product Name
缬沙坦片
Approval Number
国药准字H20223427
Approval Date
Jun 28, 2022
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy